Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

Xue-Song Sun,1–3,* Yu-Jing Liang,1–3,* Xiao-Yun Li,1–3,* Sai-Lan Liu,1–3 Qiu-Yan Chen,1–3 Lin-Quan Tang,1–3 Hai-Qiang Mai1–3 1Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, People&rsqu...

Full description

Bibliographic Details
Main Authors: Sun XS, Liang YJ, Li XY, Liu SL, Chen QY, Tang LQ, Mai HQ
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Drug Design, Development and Therapy
Subjects:
Targeted drug
chemotherapy
treatment
nasopharyngeal carcinoma and overall survival.
Online Access:https://www.dovepress.com/palliative-chemotherapy-with-or-without-anti-egfr-therapy-for-de-novo--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/palliative-chemotherapy-with-or-without-anti-egfr-therapy-for-de-novo--peer-reviewed-article-DDDT

Similar Items